NLS Pharmaceutics Ltd
(NAS:NLSP)
$
4.9
0.0246 (0.5%)
Market Cap: 5.74 Mil
Enterprise Value: 6.48 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 38/100 NLS Pharmaceutics AG at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 29, 2021 / 05:55PM GMT
Release Date Price:
$100.8
(+2.02%)
Brent Slava
Benzinga - Moderator
We're switching it up a little bit here, ladies and gentlemen, and we're going to actually do a little bit of an interview. And what do you know, I'm going to be the host for the interview. And joining for this interview, we have the CEO of NLS Pharma -- It's ticker NLSP -- Alex Zwyer. Alex, let's see Alex on screen here in a sec. There he is. How's it going, Alex?
Alex Zwyer
NLS Pharmaceutics Ltd. - CEO & Co-Founder
Hey, Brent. How are you doing? Cool shirt, by the way. Love it.
Brent Slava
Benzinga - Moderator
Thank you very much. It's -- I think it's like a Southwest United States style, I don't know if you agree. You're in New York, right, Alex? So, it's a little bit later for you obviously.
Alex Zwyer
NLS Pharmaceutics Ltd. - CEO & Co-Founder
Yes.
Brent Slava
Benzinga - Moderator
Well, thanks for staying up late with the Zinger Nation gang. We always appreciate it.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot